Comparison of 0.02% atropine eye drops, peripheral myopia defocus design spectacle lenses, and orthokeratology for myopia control.

MLA

Wang, Ming, et al. “Comparison of 0.02% Atropine Eye Drops, Peripheral Myopia Defocus Design Spectacle Lenses, and Orthokeratology for Myopia Control.” Clinical & Experimental Optometry, vol. 107, no. 8, Nov. 2024, pp. 813–19. EBSCOhost, https://doi.org/10.1080/08164622.2023.2288180.

APA

Wang, M., Ji, N., Yu, S.-A., Liang, L.-L., Ma, J.-X., & Fu, A.-C. (2024). Comparison of 0.02% atropine eye drops, peripheral myopia defocus design spectacle lenses, and orthokeratology for myopia control. Clinical & Experimental Optometry, 107(8), 813–819. https://doi.org/10.1080/08164622.2023.2288180

Chicago

Wang, Ming, Na Ji, Shi-Ao Yu, Ling-Ling Liang, Jing-Xue Ma, and Ai-Cun Fu. 2024. “Comparison of 0.02% Atropine Eye Drops, Peripheral Myopia Defocus Design Spectacle Lenses, and Orthokeratology for Myopia Control.” Clinical & Experimental Optometry 107 (8): 813–19. doi:10.1080/08164622.2023.2288180.